Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vir Biotechnology, Inc. is a biopharmaceutical company focused on developing therapies for infectious diseases and cancer. Its core activities include discovering and engineering antibodies, T-cell engagers, and siRNA treatments targeting hepatitis B, hepatitis delta, HIV, and solid tumors. Leveraging immunology, AI, and proprietary platforms, it aims to create innovative, targeted, and safer medicines to address high unmet medical needs worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.